Hormone replacement therapy and Alzheimer's disease

Area of Science:

• Neuroscience
• Endocrinology
• Gerontology

Background:

• Estrogen demonstrates beneficial effects on Alzheimer's disease (AD) risk and progression.
• Estrogen's neuroprotective mechanisms may involve enhanced cerebral blood flow, neuronal/glial stimulation, and genetic interactions.

Purpose of the Study:

• To review the existing evidence on estrogen replacement therapy (ERT) and its association with Alzheimer's disease.
• To highlight the limitations of current research and emphasize the need for more robust studies.

Main Methods:

• Review of retrospective etiological studies on ERT and AD.
• Analysis of limited follow-up studies investigating the protective effects of ERT.
• Examination of potential synergistic effects between estrogen and AD-related genetic factors.

Main Results:

• Retrospective studies suggest a beneficial role for estrogen, but their validity is limited by informant-based estrogen use history.
• Follow-up studies present mixed results, with one failing to demonstrate a protective effect.
• Evidence suggests a potential synergistic interaction between estrogen and genetic factors in AD.

Conclusions:

• Current studies on ERT for AD are generally small and lack sufficient validity.
• Larger, long-term population-based studies are crucial to definitively clarify the role of ERT in AD prevention and therapy.